Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BUPRENORPHINE\NALOXONE vs BUROSUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BUPRENORPHINE\NALOXONE vs BUROSUMAB: Safety Overview

Metric BUPRENORPHINE\NALOXONE BUROSUMAB
Total FAERS Reports 21,631 674
Deaths Reported 1,119 6
Death Rate 5.2% 0.9%
Hospitalizations 2,872 111
Average Patient Age 40.3 yrs 37.3 yrs
% Female Patients 49.1% 50.0%
Manufacturer N/A Kyowa Kirin, Inc.
Route N/A SUBCUTANEOUS